KYTHERA Articles
Bayer unit gets rights to KYTHERA’s adipolytic dermatology agent in up to $373 million deal; BTG to regain product rights from Nycomed
31 August 2010
Showing 1-1 of 1 articles
- 1
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
